Elekta AB (publ) EKTAF Stock
Elekta AB (publ) Price Chart
Elekta AB (publ) EKTAF Financial and Trading Overview
Elekta AB (publ) stock price | 5.69 USD |
Previous Close | 8.34 USD |
Open | 8.34 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 8.34 - 8.34 USD |
52 Week Range | 5.05 - 8.34 USD |
Volume | 3 USD |
Avg. Volume | 96 USD |
Market Cap | 3.19B USD |
Beta (5Y Monthly) | 1.015325 |
PE Ratio (TTM) | 41.7 |
EPS (TTM) | 0.28 USD |
Forward Dividend & Yield | 0.23 (2.75%) |
Ex-Dividend Date | February 24, 2023 |
1y Target Est | N/A |
EKTAF Valuation Measures
Enterprise Value | 3.19B USD |
Trailing P/E | 41.7 |
Forward P/E | 1.625731 |
PEG Ratio (5 yr expected) | 6.09 |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 4.0603704 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Elekta AB (publ) Stock Price History
Beta (5Y Monthly) | 1.015325 |
52-Week Change | 26.36% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8.34 USD |
52 Week Low | 5.05 USD |
50-Day Moving Average | 8.23 USD |
200-Day Moving Average | 6.72 USD |
EKTAF Share Statistics
Avg. Volume (3 month) | 96 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 382.08M |
Float | 342.91M |
Short Ratio | N/A |
% Held by Insiders | 6.16% |
% Held by Institutions | 66.42% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 1.0798 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | April 30, 2023 |
Most Recent Quarter (mrq) | April 30, 2023 |
Next Fiscal Year End | April 30, 2024 |
Profitability
Profit Margin | 5.58% |
Operating Margin (ttm) | 0% |
Gross Margin | 38.05% |
EBITDA Margin | 15.29% |
Management Effectiveness
Return on Assets (ttm) | 4.43% |
Return on Equity (ttm) | 10.12% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 20.89% |
Gross Profit (ttm) | 6.42B USD |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | 0.2 |
Quarterly Earnings Growth (yoy) | 31.19% |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | 68.51 USD |
Current Ratio (mrq) | 1.131 |
Book Value Per Share (mrq) | 2.054 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Elekta AB (publ)
Country | United States |
State | N/A |
City | Stockholm |
Address | Kungstensgatan 18 |
ZIP | 103 93 |
Phone | 46 8 58 72 54 00 |
Website | https://www.elekta.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 4700 |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Q&A For Elekta AB (publ) Stock
What is a current EKTAF stock price?
Elekta AB (publ) EKTAF stock price today per share is 5.69 USD.
How to purchase Elekta AB (publ) stock?
You can buy EKTAF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Elekta AB (publ)?
The stock symbol or ticker of Elekta AB (publ) is EKTAF.
Which industry does the Elekta AB (publ) company belong to?
The Elekta AB (publ) industry is Medical Instruments & Supplies.
How many shares does Elekta AB (publ) have in circulation?
The max supply of Elekta AB (publ) shares is 367.1M.
What is Elekta AB (publ) Price to Earnings Ratio (PE Ratio)?
Elekta AB (publ) PE Ratio is 20.32142800 now.
What was Elekta AB (publ) earnings per share over the trailing 12 months (TTM)?
Elekta AB (publ) EPS is 0.28 USD over the trailing 12 months.
Which sector does the Elekta AB (publ) company belong to?
The Elekta AB (publ) sector is Healthcare.